RecruitingNCT01577251
The Radiation Oncology Registry and Biosample Repository
Registry and Biosample Repository
Sponsor
Abramson Cancer Center at Penn Medicine
Enrollment
8,000 participants
Start Date
Jun 1, 2008
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this study is to establish a registry and biosample repository (defined as blood, urine, and tumor specimens) in patients with a cancer and/or benign tumor diagnosis undergoing radiotherapy.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Anyone age 18 and above with a cancer and/or benign tumor diagnosis undergoing radiotherapy
- Able to sign consent
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01577251
Related Trials
REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)
NCT074127821 location
ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling
NCT043411817 locations
The Sensitivity and Specificity of Sniff Dog as a Tool in Diagnosing the Suspected Tumor Patients
NCT020496581 location
The Suitability of Sniff Dog as a Tool in Screening Tumors
NCT020496451 location
The Drug Rediscovery Protocol (DRUP Trial)
NCT0292523436 locations